184 related articles for article (PubMed ID: 15346097)
1. Improving the pharmacological regimen for patients with diabetes mellitus.
Marso SP
Rev Cardiovasc Med; 2004; 5(3):139-47. PubMed ID: 15346097
[TBL] [Abstract][Full Text] [Related]
2. Optimizing the diabetic formulary: beyond aspirin and insulin.
Marso SP
J Am Coll Cardiol; 2002 Aug; 40(4):652-61. PubMed ID: 12204494
[TBL] [Abstract][Full Text] [Related]
3. Diabetes and heart disease an evidence-driven guide to risk factors management in diabetes.
Lteif AA; Mather KJ; Clark CM
Cardiol Rev; 2003; 11(5):262-74. PubMed ID: 12943604
[TBL] [Abstract][Full Text] [Related]
4. Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR).
Gudbjörnsdottir S; Eeg-Olofsson K; Cederholm J; Zethelius B; Eliasson B; Nilsson PM;
Diabet Med; 2009 Jan; 26(1):53-60. PubMed ID: 19125761
[TBL] [Abstract][Full Text] [Related]
5. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of patients with diabetes mellitus type 2 and coronary artery disease].
Wiersma JJ; Trip MD; Piek JJ
Ned Tijdschr Geneeskd; 2006 Feb; 150(7):361-6. PubMed ID: 16523798
[TBL] [Abstract][Full Text] [Related]
7. Is the current therapeutic armamentarium in diabetes enough to control the epidemic and its consequences? What are the current shortcomings?
Giugliano D; Standl E; Vilsbøll T; Betteridge J; Bonadonna R; Campbell IW; Schernthaner GH; Staels B; Trichopoulou A; Farinaro E
Acta Diabetol; 2009 Sep; 46(3):173-81. PubMed ID: 19543848
[TBL] [Abstract][Full Text] [Related]
8. Renin-Angiotensin-Aldosterone system inhibition in prevention of diabetes mellitus.
Bălută M; Vintilă V; Vintilă M
Rom J Intern Med; 2004; 42(2):277-88. PubMed ID: 15529618
[TBL] [Abstract][Full Text] [Related]
9. Type 2 diabetes mellitus: a cardiovascular perspective.
Varughese GI; Tomson J; Lip GY
Int J Clin Pract; 2005 Jul; 59(7):798-816. PubMed ID: 15963208
[TBL] [Abstract][Full Text] [Related]
10. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
Nathanson D; Nyström T
Mol Cell Endocrinol; 2009 Jan; 297(1-2):112-26. PubMed ID: 19038307
[TBL] [Abstract][Full Text] [Related]
11. [Metabolic syndrome-x at the turn of the millennium (Theoretical aspects with practical consequences)].
Halmos T; Jermendy G
Orv Hetil; 2000 Dec; 141(50):2701-9. PubMed ID: 11189676
[TBL] [Abstract][Full Text] [Related]
12. Overcoming obstacles to effective care of type 2 diabetes.
Kogan AJ
Am J Manag Care; 2009 Sep; 15(9 Suppl):S255-62. PubMed ID: 19817514
[TBL] [Abstract][Full Text] [Related]
13. The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control.
Perkins JM; Davis SN
Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):147-52. PubMed ID: 18316950
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance, diabetes and cardiovascular risk: approaches to treatment.
Rosenberg DE; Jabbour SA; Goldstein BJ
Diabetes Obes Metab; 2005 Nov; 7(6):642-53. PubMed ID: 16219008
[TBL] [Abstract][Full Text] [Related]
15. Blood pressure control, risk factors and cardiovascular prognosis in patients with diabetes: 30 years of progress.
Mourad JJ; Le Jeune S
J Hypertens Suppl; 2008 Sep; 26(3):S7-13. PubMed ID: 19363847
[TBL] [Abstract][Full Text] [Related]
16. Strategies to reduce complications of type 2 diabetes.
Ullom-Minnich P
J Fam Pract; 2004 May; 53(5):366-75. PubMed ID: 15125821
[No Abstract] [Full Text] [Related]
17. Management of hypertension in patients with chronic kidney disease and diabetes mellitus.
Palmer BF
Am J Med; 2008 Aug; 121(8 Suppl):S16-22. PubMed ID: 18638614
[TBL] [Abstract][Full Text] [Related]
18. Renin-angiotensin-system blockade in the prevention of diabetes.
Ostergren J
Diabetes Res Clin Pract; 2007 May; 76 Suppl 1():S13-21. PubMed ID: 17320999
[TBL] [Abstract][Full Text] [Related]
19. Preventing heart failure in patients with diabetes.
Srikanthan P; Hsueh W
Med Clin North Am; 2004 Sep; 88(5):1237-56. PubMed ID: 15331315
[TBL] [Abstract][Full Text] [Related]
20. Exploring the pharmacotherapeutic options for treating type 2 diabetes.
Kruger DF
Diabetes Educ; 2008; 34 Suppl 3():60S-65S. PubMed ID: 18525066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
